ANI Pharmaceuticals, Inc. (ANIP) scores 81 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Buy The estimated fair value is $152.01, representing a 106% margin of safety. Quantitative score: 86/100. Qualitative score: 60/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.